Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Cara Therapeutics, Inc.
Investment goal date:
Dividends reinvested
Cara Therapeutics, Inc. CARA report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-07
--
--
Q4 2017
2018-03-15
--
--
Q4 2017
2018-03-12
--
--
Q3 2017
2017-11-06
--
--
Q3 2017
2017-11-02
-0.3800
0.0000
Q2 2017
2017-08-03
-0.2900
-0.2900
Q1 2017
2017-05-04
-0.8100
-0.8100
Q4 2016
2017-03-09
-0.8100
-0.8100
Q3 2016
2016-11-03
-0.4200
-0.4200
Q2 2016
2016-08-04
-0.4800
-0.4800
Q1 2016
2016-05-05
-0.3900
-0.3900
Q4 2015
2016-03-10
-0.3500
-0.3500
Q3 2015
2015-11-09
-0.1900
-0.1900
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BlackRock Fund Advisors
692518
BlackRock Inc.
1412092
BlackRock Institutional Trust Company, N.A.
754488
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD
960508
DISCIPLINED GROWTH INVESTORS INC /MN
876550
EverPoint Asset Management, LLC
500000
FMR LLC
938776
FRANKLIN RESOURCES INC
592300
JENNISON ASSOCIATES LLC
300000
JPMORGAN CHASE & CO
346724
MORGAN STANLEY
332606
Opaleye Management Inc.
385000
RHO CAPITAL PARTNERS INC
3568057
STATE STREET CORP
412739
Vanguard Group, Inc
943627
Major Shareholders
Name Relationship
Total Shares
Holding stocks
CHALMERS DEREK T
4.7800% (1082292)
CARA /
CHALMERS DEREK T
4.8000% (1086292)
CARA /
VOGELBAUM MARTIN
13.5500% (3068057)
CARA / NRX /
ALTA BIOPHARMA PARTNERS III LP
0.1900% (43212)
Lewis Michael E
1.3900% (314988)
CARA /
RHO Ventures VI LP
15.7600% (3568057)
CARA /
Stauffer Joseph William
0.0600% (13442)
CARA / DRRX /
Menzaghi Frederique Ph.D.
0.5200% (117000)
CARA /
Menzaghi Frederique Ph.D.
0.6000% (137000)
CARA /
Moller Charles Ph.D.
6.9600% (1576404)
CARA /
Schoell Josef
0.2200% (50000)
CARA /
% ()